FDA
approval
· 2024-01-12
FDA Approved: MESALAMINE — Supplemental Application (Zydus Lifesciences Limited)
Summary
FDA approved a supplemental application for Mesalamine filed by Zydus Lifesciences Limited under the ANDA pathway.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for MESALAMINE (MESALAMINE)